Stemsight

Developer of cell therapies for corneal blindness

placeTampere, Pirkanmaa, Finland calendar_todayFounded 2021 groups8 employees language stemsight.fi

Social engagement

Social engagement: 2.1K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Voima Ventures.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%

Recent activity

17 Apr 2026
Event
Anglonordic Life Science conference
14 Apr 2026
Event
BioTrinity life science investment conference
25 Mar 2026
Event
Visionary Foresight: Pioneering Cell-Based Therapies
Coming soon